Related Experiment Videos
[Placebo in drug clinical trials]
F García-Alonso1, E Guallar, O M Bakke
1Centro Nacional de Farmacobiología, Instituto de Salud Carlos III, Madrid.
Medicina Clinica
|March 11, 1998
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
High prevalence of non-alcoholic fatty liver disease and metabolic risk factors in Guatemala: A population-based study.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2018
The cohabitation of academia and industry: What position do the medical journals take regarding opinion articles?
Revista clinica espanola·2016
Lower-normal TSH is associated with better metabolic risk factors: A cross-sectional study on Spanish men.
Nutrition, metabolism, and cardiovascular diseases : NMCD·2015
In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci.
The Journal of antimicrobial chemotherapy·2014
In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria.
Antimicrobial agents and chemotherapy·2013
Foundations for the rational prescription of enteral medical nutrition therapy.
Medicina clinica·2026
Eating disorders.
Medicina clinica·2026
Defining nonfatal opioid overdoses using administrative health data in the United States and Canada: A scoping review.
Preventive medicine reports·2026
Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing.
Frontiers in neuroscience·2026
Association between opioid use and treatment discontinuation in patients receiving nivolumab: a real-world database study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Signal detection and characterisation of a novel drug-drug interaction between methadone and a synthetic cannabinoid receptor agonist.
British journal of pharmacology·2026